<DOC>
	<DOCNO>NCT00971308</DOCNO>
	<brief_summary>The purpose study determine antiviral effect follow three day dose BMS-824393 chronically genotype subtype 1a 1b Hepatitis C virus ( HCV ) infect subject .</brief_summary>
	<brief_title>Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<criteria>Treatment naive chronically infected subject Hepatitis C Virus genotype 1 HCV RNA viral load ≤10*5* IU/mL ( 100,000 IU/mL ) Body Mass Index ( BMI ) 18 35 kg/m² , inclusive Women pregnant breast feed Any significant acute chronic medical illness stable control medication consistent Hepatitis C infection Any medical , psychiatric and/or social reason , opinion Investigator , would make candidate inappropriate participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>